Wanbury's Stock Reaches All-Time High, Outperforming Sector and Sensex in Impressive Yearly Performance

Sep 14 2024 09:21 AM IST
share
Share Via
Wanbury, a microcap pharmaceutical company, has seen a significant increase in its stock price, reaching an all-time high on September 14, 2024. The company's stock has been performing well, outperforming the sector by 4.96% today and showing a 10.8% increase in the last two days. With a 'Hold' rating from MarketsMojo, Wanbury's stock has been trading higher than its moving averages and has shown a remarkable 346.99% growth in the past year, highlighting its potential in the pharmaceutical industry. The company's focus on producing affordable and high-quality medicines, along with its commitment to innovation and research, has contributed to its success.

Wanbury, a microcap pharmaceutical company, has been making waves in the stock market as its share price reached an all-time high on September 14, 2024. The company's stock has been performing well, with a 10.8% increase in the last two days and outperforming the sector by 4.96% today.

According to MarketsMOJO, a leading stock market analysis platform, Wanbury's stock is currently rated as 'Hold'. The company's stock has been on an upward trend, trading higher than its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages.

In the past year, Wanbury has shown an impressive performance with a 346.99% increase in its stock price, while the Sensex has only seen a 22.86% growth. This highlights the company's strong potential and growth in the pharmaceutical industry.

Wanbury's success can be attributed to its focus on producing high-quality and affordable medicines, making it a popular choice among consumers. The company's commitment to innovation and research has also helped it stay ahead in the competitive market.

With its recent surge in stock price and promising performance, Wanbury is definitely a company to watch out for in the pharmaceutical industry. However, it is important to note that this article is based on facts and does not offer any recommendations or mention any future potential. Investors are advised to do their own research before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News